DiscoverBioTech Nation ... with Dr. Moira GunnWhy One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals
Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals

Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals

Update: 2025-03-05
Share

Description

This week on BioTech Nation, Catalyst Pharmaceuticals CEO Rich Daly discusses the complexities of treating epilepsy and rare diseases. From the challenges of polypharmacy—where patients need multiple drugs to manage a single condition—to the hurdles of diagnosing and treating ultra-rare diseases. 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals

Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals

Moira Gunn